Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 1,366 shares at $9.05 ($12K) on 2022-02-16, disclosed to the SEC on 2022-02-18.
Seasonal sale ($12k) by Chief Scientific Officer — this insider has traded DCPH in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| DCPH | SELL | 2023-01-19 | $102K | — | Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2021-02-18 | $25K | — | Filing → |